Wanita Dewasa Muda dengan Gagal Jantung, Pneumonia, dan Hipoksemia: Komplikasi Obesitas Morbid – Laporan Kasus
Laporan Kasus
DOI:
https://doi.org/10.55175/cdk.v53i03.1776Kata Kunci:
Gagal jantung, HFpEF, hipoksemia, laporan kasus, obesitas, pneumoniaAbstrak
Pendahuluan: Gagal jantung merupakan sindrom klinis akibat abnormalitas struktur ataupun fungsi jantung yang menyebabkan gejala kardinal dan tanda-tanda gagal jantung. Salah satu penyebab peningkatan kejadian gagal jantung pada usia muda adalah meningkatnya kejadian obesitas. Obesitas juga meningkatkan risiko gangguan fungsi paru dan organ-organ lainnya. Kasus: Wanita berusia 25 tahun dengan sesak napas sejak 1 hari. Saturasi oksigen perifer (SpO2) 80% pada udara ruangan. Indeks massa tubuh (IMT) 52 kg/m2. Radiologi toraks menunjukkan kardiomegali dengan edema paru dan infiltrat paru. Ekokardiografi menunjukkan fraksi ejeksi ventrikel kiri 79,8% dan disfungsi diastolik ringan ventrikel kiri. Pembahasan: Pasien didiagnosis gagal jantung dengan fraksi ejeksi terjaga (HFpEF) dan pneumonia. Pengobatan dengan furosemide dan antibiotik berhasil mengurangi gejala sesak napas, kongesti, dan infiltrat paru, namun tetap hipoksemia pada udara ruangan. Fisioterapi dada dan latihan pernapasan dilakukan untuk menangani gangguan fungsi paru akibat obesitas. Simpulan: Obesitas merupakan salah satu faktor risiko gagal jantung pada populasi dewasa muda. Menjaga berat badan ideal penting untuk mencegah obesitas beserta komplikasinya.
Unduhan
Referensi
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599−726. doi: 10.1093/eurheartj/ehab368.
Lecoeur E, Domeng O, Fayol A, Jannot AS, Hulot JS. Epidemiology of heart failure in young adults: a French nationwide cohort study. Eur Heart J. 2023;44(5):383−92. doi: 10.1093/eurheartj/ehac651.
Kementerian Kesehatan Republik Indonesia. Survei Kesehatan Indonesia 2023. Jakarta: Kementrian Kesehatan Republik Indonesia; 2023. p.894-7.
Kalra S, Kapoor N, Bhattacharya S, Aydin H, Coetzee A. Barocrinology: the endocrinology of obesity from bench to bedside. Med Sci (Basel).2020;8(4):51. doi: 10.3390/medsci8040051.
Littleton SW, Tulaimat A. The effects of obesity on lung volumes and oxygenation. Respir Med. 2017;124:15−20. doi: 10.1016/j.rmed.2017.01.004.
Dobrowolski P, Prejbisz A, Kurylowicz A, Baska A, Burchardt P, Chlebus K, et al. Metabolic syndrome - a new definition and management guidelines: a joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, "Club 30" Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons. Arch Med Sci. 2022;18(5):1133−56. doi: 10.5114/aoms/152921.
Members WC, Members AAJC. 2022 AHA/ACC/HFSA guideline for the management of heart failure. J Card Fail. 2022;28(5):e1−e167. doi: 10.1016/j.cardfail.2022.02.010.
Kementerian Kesehatan Republik Indonesia. Laporan Nasional Riskesdas 2018. Jakarta: Lembaga Penerbit Badan Penelitian dan Pengembangan Kesehatan; 2019. p.580-3.
Ikeda Y, Iwakawa M, Kiyokawa H, Nakagami T, Kanzaki S, Ogawa A, et al. A case of young obese heart failure patient using multidisciplinary treatment centered on the fantastic four improved cardio ankle vascular index and cardiac function. Int Med Case Rep J. 2023;16:545−9. doi:10.2147/IMCRJ.S424567.
Tromp J, Paniagua SMA, Lau ES, Allen NB, Blaha MJ, Gansevoort RT, et al. Age dependent associations of risk factors with heart failure: pooled population based cohort study. BMJ. 2021;372:n461. doi: 10.1136/bmj.n461.
Hall EJ, Menachem J, Stevenson LW, Huston J. Easily missed: a case series of new heart failure in young adults. Case Rep Med. 2020;2020:7251609. doi: 10.1155/2020/7251609.
Christiansen MN, Kober L, Weeke P, Vasan RS, Jeppesen JL, Smith JG, et al. Age-specific trends in incidence, mortality, and comorbidities of heart failure in Denmark, 1995 to 2012. Circulation 2017;135(13):1214−23. doi: 10.1161/CIRCULATIONAHA.116.025941.
Rosengren A, Aberg M, Robertson J, Waern M, Schaufelberger M, Kuhn G, et al. Body weight in adolescence and long-term risk of early heart failure in adulthood among men in Sweden. Eur Heart J. 2017;38(24):1926−33. doi: 10.1093/eurheartj/ehw221.
Borlaug BA, Jensen MD, Kitzman DW, Lam CSP, Obokata M, Rider OJ. Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets. Cardiovasc Res. 2023;118(18):3434−50. doi: 10.1093/cvr/cvac120.
Lembo M, Strisciuglio T, Fonderico C, Mancusi C, Izzo R, Trimarco V, et al. Obesity: the perfect storm for heart failure. ESC Heart Fail. 2024;11(4):1841−60. doi: 10.1002/ehf2.14641.
Sulistiowati E, Sihombing M. NCEP-ATP III and IDF criteria for metabolic syndrome predict type 2 diabetes mellitus. Univ Med. 2016;35(1):46−55. doi: 10.18051/UnivMed.2016.v35.46-55.
Herningtyas EH, Ng TS. Prevalence and distribution of metabolic syndrome and its components among provinces and ethnic groups in Indonesia. BMC Publ Health. 2019;19(1):377. doi: 10.1186/s12889-019-6711-7.
Shah SA, Mir RA, Quraishi KA, Dar UK. Metabolic syndrome: a crucial risk factor for dermatophytosis. Int J Res Med Sci. 2023;11(2):622−5. doi: 10.18203/2320-6012.ijrms20230175.
Son JH, Doh JY, Han K, Kim YH, Han JH, Bang CH, et al. Risk factors of dermatophytosis among Korean adults. Sci Rep. 2022;12(1):13444. doi: 10.1038/s41598-022-17744-5.
Makhijani P, Basso PJ, Chan YT, Chen N, Baechle J, Khan S, et al. Regulation of the immune system by the insulin receptor in health and disease. Front Endocrinol (Lausanne). 2023;14:1128622. doi: 10.3389/fendo.2023.1128622.
Frasca D, McElhaney J. Influence of obesity on pneumococcus infection risk in the elderly. Front Endocrinol (Lausanne). 2019;10:71. doi:10.3389/fendo.2019.00071.
Wu X, Li Z, Cao J, Jiao J, Wang Y, Liu G, et al. The association between major complications of immobility during hospitalization and quality of life among bedridden patients: a 3 month prospective multi-center study. PLoS One. 2018;13(10):e0205729. doi: 10.1371/journal.pone.0205729.
Shah NM, Kaltsakas G. Respiratory complications of obesity: from early changes to respiratory failure. Breathe (Sheff). 2023;19(1):220263. doi: 10.1183/20734735.0263-2022.
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, et al. 2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023;44(37):3627−39. doi: 10.1093/eurheartj/ehad195.
Wilding JPH, Batterham RL, Calanna S, Davies M, Gaal LFV, Lingvay I, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989−1002. doi: 10.1056/NEJMoa2032183.
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2026 David Kristianus, Robert Noldy Ngantung, Hari Sutanto
Artikel ini berlisensi Creative Commons Attribution-NonCommercial 4.0 International License.
